Reproducibility and responsiveness of the Symptom Severity Scale and the hand and finger function subscale of the Dutch

  • PDF / 523,334 Bytes
  • 9 Pages / 610 x 792 pts Page_size
  • 34 Downloads / 219 Views

DOWNLOAD

REPORT


Open Access

Research

Reproducibility and responsiveness of the Symptom Severity Scale and the hand and finger function subscale of the Dutch arthritis impact measurement scales (Dutch-AIMS2-HFF) in primary care patients with wrist or hand problems Marinda N Spies-Dorgelo*1,2, Caroline B Terwee2, Wim AB Stalman1,2 and Daniëlle AWM van der Windt1,2,3 Address: 1Department of General Practice, VU University Medical Center, Amsterdam, The Netherlands, 2Institute for Research in Extramural Medicine, VU University Medical Center, Amsterdam, The Netherlands and 3Primary Care Musculoskeletal Research Centre, Keele University, Keele, UK Email: Marinda N Spies-Dorgelo* - [email protected]; Caroline B Terwee - [email protected]; Wim AB Stalman - [email protected]; Daniëlle AWM van der Windt - [email protected] * Corresponding author

Published: 10 November 2006 Health and Quality of Life Outcomes 2006, 4:87

doi:10.1186/1477-7525-4-87

Received: 04 October 2006 Accepted: 10 November 2006

This article is available from: http://www.hqlo.com/content/4/1/87 © 2006 Spies-Dorgelo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract Background: To determine the clinimetric properties of two questionnaires assessing symptoms (Symptom Severity Scale) and physical functioning (hand and finger function subscale of the AIMS2) in a Dutch primary care population. Methods: The first 84 participants in a 1-year follow-up study on the diagnosis and prognosis of hand and wrist problems completed the Symptom Severity Scale and the hand and finger function subscale of the Dutch-AIMS2 twice within 1 to 2 weeks. The data were used to assess test-retest reliability (ICC) and smallest detectable change (SDC, based on the standard error of measurement (SEM)). To assess responsiveness, changes in scores between baseline and the 3 month follow-up were related to an external criterion to estimate the minimal important change (MIC). We calculated the group size needed to detect the MIC beyond measurement error. Results: The ICC for the Symptom Severity Scale was 0.68 (95% CI: 0.54–0.78). The SDC was 1.00 at individual level and 0.11 at group level, both on a 5-point scale. The MIC was 0.23, exceeding the SDC at group level. The group size required to detect a MIC beyond measurement error was 19 for the Symptom Severity Scale. The ICC for the hand and finger function subscale of the DutchAIMS2 was 0.62 (95% CI: 0.47–0.74). The SDC was 3.80 at individual level and 0.42 at group level, both on an 11-point scale. The MIC was 0.31, which was less than the SDC at group level. The group size required to detect a MIC beyond measurement error was 150. Conclusion: In our heterogeneous primary care population the Symptom Severity Scale was found to be a suitable instrument to assess the severity